Mechanisms of cytoplasmic {beta}-catenin accumulation and its involvement in tumorigenic activities mediated by oncogenic splicing variant of the receptor originated from Nantes tyrosine kinase.
about
Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addictionRibosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating proteinVariant RONΔ160 of the RON receptor tyrosine kinase promotes the growth and invasion in vitro and in vivo in gastric cancer cell lines.Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia.Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-OncogeneRecepteur d'Origine nantais (RON) tyrosine kinase splicing variants lacking exons 18 and 19 occur ubiquitously in lung cancerA novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma.Significance of the entire C-terminus in biological activities mediated by the RON receptor tyrosine kinase and its oncogenic variant RON160Alternative splicing and tumor progression.Autoinhibition of the Ron receptor tyrosine kinase by the juxtamembrane domain.RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential
P2860
Q26864275-FD16973C-6F01-456E-A771-C74C37080D8AQ35053054-0F224F90-D656-40B9-99C8-19170492109AQ35079037-E9FC0F7B-3D34-4E5A-B276-E078704430CDQ35577352-783A0936-9FC0-4F8F-8DD5-4B04E8D0E117Q36140785-69798138-E846-4AAE-A4E4-3922C27A1838Q36275040-9EA8843F-DE37-47B0-9818-DD2C68DD1D43Q36492850-B0DB4191-8203-4A2F-82D3-5ACCFB32247CQ36814075-72C5EF61-17A5-4640-B948-DB3070185186Q36887780-D842A3AF-B8D5-463E-AD51-9249F53CFFD1Q36975164-9022202B-A72D-4BC4-B24D-75EFD5739B4EQ37222930-1F7B2545-80D4-490D-8C2F-6CF9A0ED5733Q39628474-B53209E6-C91C-42A1-BEC5-E750F0739A7EQ53591553-891AD4E0-3BB2-4230-8F83-769B86A85ADDQ59130211-6582B108-FD1B-4FEB-92C6-E5916B8F3F0D
P2860
Mechanisms of cytoplasmic {beta}-catenin accumulation and its involvement in tumorigenic activities mediated by oncogenic splicing variant of the receptor originated from Nantes tyrosine kinase.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Mechanisms of cytoplasmic {bet ...... d from Nantes tyrosine kinase.
@en
Mechanisms of cytoplasmic {bet ...... d from Nantes tyrosine kinase.
@nl
type
label
Mechanisms of cytoplasmic {bet ...... d from Nantes tyrosine kinase.
@en
Mechanisms of cytoplasmic {bet ...... d from Nantes tyrosine kinase.
@nl
prefLabel
Mechanisms of cytoplasmic {bet ...... d from Nantes tyrosine kinase.
@en
Mechanisms of cytoplasmic {bet ...... d from Nantes tyrosine kinase.
@nl
P2093
P2860
P356
P1476
Mechanisms of cytoplasmic {bet ...... d from Nantes tyrosine kinase.
@en
P2093
Ming-Hai Wang
Xiang-Ming Xu
Yong-Qing Zhou
P2860
P304
25087-25094
P356
10.1074/JBC.M414699200
P407
P577
2005-05-06T00:00:00Z